Aligos Therapeutics Inc (ALGS) — Cash Flow Quality Index

Latest as of March 2025: -0.49x

Aligos Therapeutics Inc (ALGS) has a Cash Flow Quality Index of -0.49x as of March 2025. Operating cash flow of $-20.91 Million is below net income of $43.09 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ALGS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.49x

Operating CF / Net Income

Operating Cash Flow

$-20.91 Million

USD

Net Income

$43.09 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Aligos Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Aligos Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.